Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1993-12-08
1995-08-15
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514912, A61K 3150
Patent
active
054419581
ABSTRACT:
Topical ophthalmic compositions comprising 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimidazole and its ophthalmically acceptable acid addition salts have been found to be useful in treating allergic conjunctivitis and related ailments.
REFERENCES:
patent: 4430343 (1984-02-01), Iemura et al.
patent: 5192780 (1993-03-01), York et al.
Miller, J. et al., "Antazoline phosphate and naphazoline hydrochloride, singly and in combination for the treatment of allergic conjunctivitis-a controlled, double-blind clinical trial," Ann. Allergy., 35:81-86 (1975).
Vandewalker, M. L., et al., "Efficacy of Vasocon-A and its components with conjunctival provaction testing (CPT)," J. Allergy Clin. Immunol., 83:302 (1989).
Abelson, M. B., et al., "Effects of topically applied ocular decongestant and antihistamine," Am. J. Ophthalmol., 90:254-257 (1980).
DeChant, K. L. and K. L. Goa, "Levocabastine. A Review of its pharmaceutical properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis," Drugs, 41:202-224 (1991).
Berdy et al., "Allergic conjunctivitis: A survey of new antihistamines," J. Ocular Pharmacol., 7:313-324 (1991).
Yanni et al., "Effect of Lodoxamide on in vitro and in vivo conjunctival immediate hypersensitivity responses in rats," Int. Arch. Allergy Immunol., 101:102-106 (1993).
Dunnett, C. W., "A multiple comparison procedure for comparing treatments with a control," J. Am. Stat. Assoc., 50:1096-1121 (1955).
Bliss, C. and E. Gjorgy, Vitamin Methods, vol. 2, pp. 445-610, Academic Press, Inc. New York (1951).
Okumura Shigetoshi
Robertson Stella M.
Saito Tadayuki
Tanaka Hitoshi
Yanni John M.
Alcon Laboratories Inc.
Fay Zohreh
Yeager Sally
LandOfFree
Ophthalmic compositions comprising emedastine and methods for th does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ophthalmic compositions comprising emedastine and methods for th, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ophthalmic compositions comprising emedastine and methods for th will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2181946